MSP Recovery (MSPR)
NASDAQ:MSPR
US Market
Advertisement

MSP Recovery (MSPR) AI Stock Analysis

Compare
456 Followers

Top Page

MSPR

MSP Recovery

(NASDAQ:MSPR)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 4o)
Rating:41Neutral
Price Target:
$0.50
▲(11.11% Upside)
MSPR's overall stock score is primarily impacted by its poor financial performance, with significant losses and high leverage. Technical analysis further indicates bearish momentum, while valuation metrics are weak due to negative earnings. The absence of earnings call data and corporate events leaves these areas unaddressed.

MSP Recovery (MSPR) vs. SPDR S&P 500 ETF (SPY)

MSP Recovery Business Overview & Revenue Model

Company DescriptionMSP Recovery (MSPR) is a leading healthcare recovery and data analytics company that specializes in identifying and recovering funds owed to Medicare and other healthcare programs. The company operates primarily in the healthcare sector, focusing on managing claims and ensuring that the appropriate reimbursements are made to healthcare providers. MSPR leverages advanced technology and a proprietary database to streamline the recovery process and enhance the accuracy of its services.
How the Company Makes MoneyMSP Recovery generates revenue through a contingency-based model, where it receives a percentage of the funds recovered on behalf of its clients, which primarily include healthcare providers and payers. Key revenue streams include recovery fees from successful claims, analytics services that provide insights into recovery opportunities, and partnerships with healthcare organizations that enable access to larger datasets for more efficient recovery processes. Additionally, MSPR may engage in settlements with various healthcare programs, further contributing to its earnings.

MSP Recovery Earnings Call Summary

Earnings Call Date:May 15, 2024
(Q1-2024)
|
% Change Since: |
Next Earnings Date:Nov 12, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted LifeWallet's successful settlements and increased claims recovery income, demonstrating progress in its core business model. However, the company also reported a significant operating loss, primarily due to noncash items. Overall, while there are substantial achievements, the financial results reflect ongoing challenges.
Q1-2024 Updates
Positive Updates
Successful Settlements with Insurers
LifeWallet achieved two comprehensive settlements with multiple property and casualty insurers, resolving claims and establishing a process for future claims. The settlements include provisions for data sharing and a 5-year agreement for binding mediation of Medicare claim liens.
Increased Claims Recovery Income
The company generated claims recovery income of $6 million in Q1 2024, up from $3.5 million in Q1 2023, indicating progress in its recovery strategies.
Expansion of Data Collaboration
LifeWallet entered into a tri-party data collaboration agreement with Palantir Technologies and 28 affiliated settling counterparties to enhance its ability to reconcile Medicare liabilities.
Liquidity and Financial Flexibility
LifeWallet extended its obligations with Virage, Nomura, and Yorkville to 2025, and secured a working capital credit facility with an additional $14 million borrowing capacity.
Negative Updates
Significant Operating Loss
LifeWallet reported an operating loss of $130 million for Q1 2024, with 93% attributed to noncash items such as claims amortization expense.
Intangible Asset Decrease
Total assets decreased by $124 million from December 31, 2023, primarily due to the amortization of intangible assets.
Company Guidance
During the LifeWallet First Quarter 2024 earnings call, the company provided guidance highlighting significant achievements and financial metrics. LifeWallet reached two comprehensive settlements with property and casualty insurers, which included agreements to provide 10 years of historical data and to collaboratively resolve future Medicare claims. These settlements resulted in claims recovery income of $6 million for Q1 2024, an increase from the $3.5 million reported in Q1 2023. The company reported a total operating loss of $130 million, primarily driven by non-cash items, with an adjusted operating loss of $8.7 million after excluding claims amortization expenses. LifeWallet's total assets were valued at $3 billion, with liabilities amounting to $1.8 billion. The company has extended various obligations to 2025 and secured additional liquidity through a working capital credit facility and a Yorkville standby equity purchase agreement, ensuring its ability to meet cash obligations over the next year.

MSP Recovery Financial Statement Overview

Summary
MSPR faces significant financial difficulties, with persistent losses, high leverage, and negative cash flows. The income statement shows negative net profit margins and declining EBIT and EBITDA margins. The balance sheet indicates high financial leverage and negative stockholders' equity. Cash flow analysis reveals negative operating and free cash flows, highlighting liquidity challenges.
Income Statement
15
Very Negative
The income statement reveals significant challenges, with negative net profit margins and declining EBIT and EBITDA margins over time. Despite a slight revenue growth in the TTM period, the company struggles with profitability, as evidenced by substantial net losses and negative EBIT margins.
Balance Sheet
10
Very Negative
The balance sheet indicates high financial leverage with a negative stockholders' equity and a concerning debt-to-equity ratio. The negative return on equity further highlights the company's inability to generate profits from its equity base, posing substantial financial risk.
Cash Flow
20
Very Negative
Cash flow analysis shows negative operating and free cash flows, with a slight improvement in free cash flow to net income ratio. However, the overall negative cash flow position and declining free cash flow growth rate underscore liquidity challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue13.28M18.25M7.71M23.42M14.63M13.89M
Gross Profit4.63M8.64M5.56M21.37M14.09M13.71M
EBITDA-584.24M-652.46M-545.71M-280.47M-5.52M-3.15M
Net Income-581.26M-360.50M-56.35M-7.42M-33.09M-24.25M
Balance Sheet
Total Assets1.67B1.92B3.16B3.42B104.01M17.84M
Cash, Cash Equivalents and Short-Term Investments3.99M12.33M11.63M3.66M1.66M11.88M
Total Debt861.21M794.66M679.22M324.25M213.61M48.09M
Total Liabilities2.28B2.05B1.74B1.23B255.41M133.69M
Stockholders Equity-207.16M100.58M272.39M109.69M-155.76M-120.18M
Cash Flow
Free Cash Flow-23.16M-16.65M-41.77M-83.62M1.62M-344.00K
Operating Cash Flow-20.61M-16.12M-40.02M-80.64M2.25M-14.00K
Investing Cash Flow-111.38M-2.73M7.56M-5.68M-2.01M986.00K
Financing Cash Flow20.03M19.54M29.02M99.73M-10.46M9.61M

MSP Recovery Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.45
Price Trends
50DMA
1.03
Negative
100DMA
3.34
Negative
200DMA
7.96
Negative
Market Momentum
MACD
-0.22
Negative
RSI
39.97
Neutral
STOCH
30.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MSPR, the sentiment is Negative. The current price of 0.45 is below the 20-day moving average (MA) of 0.59, below the 50-day MA of 1.03, and below the 200-day MA of 7.96, indicating a bearish trend. The MACD of -0.22 indicates Negative momentum. The RSI at 39.97 is Neutral, neither overbought nor oversold. The STOCH value of 30.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MSPR.

MSP Recovery Risk Analysis

MSP Recovery disclosed 95 risk factors in its most recent earnings report. MSP Recovery reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

MSP Recovery Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
44
Neutral
$17.36M-0.24187.24%82.90%
41
Neutral
$996.00K-2151.29%76.98%-52.89%
22
Underperform
$46.00K-728.82%1049.89%66.27%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MSPR
MSP Recovery
0.45
-11.38
-96.20%
WORX
SCWorx
0.29
-0.69
-70.41%
ONMD
OneMedNet
1.40
0.53
60.92%
FOXO
FOXO Technologies
0.01
-14.12
-99.93%
VSEE
VSee Health
0.74
-0.60
-44.78%
ACON
Aclarion, Inc.
6.16
-1,574.00
-99.61%

MSP Recovery Corporate Events

MSP Recovery Delays Q3 2025 Form 10-Q Filing
Nov 14, 2025

MSP Recovery, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The primary reason for this delay is the recent transition in audit firms, with Baker Tilly US, LLP taking over as the independent registered public accounting firm. This transition has resulted in incomplete required activities with the predecessor audit firm, delaying the review of the consolidated financial statements. The company anticipates filing the delayed report within the five-day grace period allowed under Rule 12b-25. MSP Recovery does not expect any significant changes in its financial results compared to the previous year. The company is actively working with its new auditor to ensure compliance, as stated by Francisco Rivas-Vásquez, the Chief Financial Officer.

The most recent analyst rating on (MSPR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Delistings and Listing ChangesPrivate Placements and Financing
MSP Recovery Faces Nasdaq Delisting Notification
Negative
Oct 28, 2025

On October 28, 2025, MSP Recovery, Inc. and Yorkville reached an agreement to reduce the Floor Price under their Standby Equity Purchase Agreement from $1.00 to $0.50. Additionally, MSP Recovery amended its promissory note with Nomura to reflect a principal amount of $35.4 million and secured a waiver for $3.0 million to fund operations. Despite these financial maneuvers, MSP Recovery received a delisting notification from Nasdaq on October 22, 2025, due to non-compliance with stockholder equity requirements. The company intends to appeal the decision, with the possibility of its stock trading on the OTCQB Venture Market if delisted from Nasdaq.

The most recent analyst rating on (MSPR) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Executive/Board ChangesPrivate Placements and Financing
MSP Recovery Secures Additional Funding in Equity Agreement
Neutral
Oct 10, 2025

MSP Recovery entered into a Standby Equity Purchase Agreement with Yorkville, allowing the company to sell up to $250 million of its common stock. As part of this agreement, Yorkville advanced funds through convertible promissory notes, with a recent second supplemental agreement on October 10, 2025, providing additional funding of up to $3 million. The conversion terms were adjusted, including a change in the floor price from $1.20 to $1.00 per share. Additionally, on October 7, 2025, Alexandra Plasencia, the General Counsel, announced her resignation effective October 17, 2025, but will assist in the transition until November 30, 2025.

The most recent analyst rating on (MSPR) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Business Operations and Strategy
MSP Recovery Adjusts Yorkville SEPA Floor Price
Neutral
Sep 29, 2025

On September 29, 2025, MSP Recovery and Yorkville agreed to lower the Floor Price under the Yorkville SEPA from $1.60 to $1.20. This adjustment in the agreement could potentially impact the financial terms and conditions between the parties, influencing MSP Recovery’s financial strategy and market positioning.

The most recent analyst rating on (MSPR) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Business Operations and StrategyLegal Proceedings
MSP Recovery Reaches $2.9 Million Settlement Agreements
Neutral
Sep 19, 2025

MSP Recovery, Inc. has reached confidential settlement agreements totaling $2.9 million in cash, involving a property and casualty insurer and a pharmaceutical defendant. The settlements include agreements to provide historical data and resolve Medicare claims, as well as addressing overpayments in a prescription drug scheme, potentially impacting the company’s operations and financial positioning.

The most recent analyst rating on (MSPR) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
MSP Recovery Adjusts Floor Price in Yorkville SEPA
Neutral
Sep 15, 2025

On September 15, 2025, MSP Recovery and Yorkville agreed to lower the Floor Price under the Yorkville SEPA from $2.00 to $1.60. This adjustment may impact MSP Recovery’s financial strategies and stakeholder interests by potentially altering the company’s capital structure and market positioning.

The most recent analyst rating on (MSPR) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Legal Proceedings
MSP Recovery Settles Litigation with Cano Health
Neutral
Sep 10, 2025

On September 8, 2025, MSP Recovery, LLC, a subsidiary of MSP Recovery, Inc., reached a settlement with Cano Health, LLC, resolving litigation that began on August 10, 2023. The settlement, which involved dismissing all claims with prejudice, eliminates previously disclosed risks associated with the litigation and is not expected to materially impact MSP Recovery’s financial condition or operations.

The most recent analyst rating on (MSPR) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
MSP Recovery Lowers Floor Price in Yorkville SEPA
Neutral
Sep 5, 2025

On September 5, 2025, MSP Recovery and Yorkville agreed to lower the Floor Price under the Yorkville SEPA from $3.50 to $2.00. This adjustment could potentially impact the company’s financial arrangements and market strategy, influencing stakeholder interests.

The most recent analyst rating on (MSPR) stock is a Sell with a $2.00 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Stock Split
MSP Recovery Implements Reverse Stock Split
Neutral
Sep 2, 2025

On September 1, 2025, MSP Recovery, Inc. implemented a reverse stock split, consolidating every seven shares of its Class A and Class V Common Stock into one share, without altering the par value. This move, approved by a majority of stockholders on August 18, 2025, aimed to increase the market price per share to comply with Nasdaq rules. The reverse split reduced the number of Class A shares from approximately 7.2 million to 1 million and Up-C Units from 3.3 million to 0.5 million, affecting all stockholders uniformly without altering their percentage ownership.

The most recent analyst rating on (MSPR) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Business Operations and StrategyLegal Proceedings
MSP Recovery Subsidiary Liable for $12.7M in Damages
Negative
Aug 26, 2025

On August 20, 2025, a jury in the Menendez Litigation found MSP Recovery, LLC, a subsidiary of MSP Recovery, Inc., liable for breach of an alleged oral contract, awarding plaintiffs $12.7 million in damages. Although the jury exonerated the parent company and its CEO, John H. Ruiz, from fraud and misrepresentation claims, the verdict has introduced uncertainty regarding the company’s financial condition and may impact its ability to raise capital or continue operations. The company plans to challenge the verdict through post-trial motions and potential appeals.

The most recent analyst rating on (MSPR) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on MSP Recovery stock, see the MSPR Stock Forecast page.

Shareholder MeetingsStock Split
MSP Recovery Approves Reverse Stock Split Amendment
Neutral
Aug 18, 2025

On August 18, 2025, MSP Recovery, Inc. held a Special Meeting of its Stockholders, where approximately 74.74% of stockholders were present. During the meeting, stockholders approved an amendment to the company’s Charter for a reverse stock split at a ratio between 1-for-2 and 1-for-7, and the issuance of Class A Common Stock to Virage Recovery Master LP, in compliance with Nasdaq Listing Rule 5635(d).

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 15, 2025